Description

Book Synopsis
Free digital access available with every print purchase. See inside the book for more details.

While classification of pancreatic neoplasms has not evolved significantly since 2007, data related to the molecular underpinnings that characterize each type of neoplasm have grown exponentially in the past 15 years. The current multimodal study of pancreatic neoplasms has allowed a better understanding of tumor biology, more closely linking the mor¬phologic findings with clinical outcomes and targeted treatment. The prognosis of conventional pancreatic ductal adenocarcinoma remains very poor, but some promise is on the horizon based on novel treatment approaches and the increase in earlier diagnosis. Furthermore, intensive study of other pancreatic neoplasms has led to a clearer recognition that each type has distinctive biology and behavior that is often not so highly aggressive. This sense of optimism may help drive a resurgence of interest in pancreatic pathology.

Tumors of the Pancreas

    Product form

    £186.30

    Includes FREE delivery

    RRP £207.00 – you save £20.70 (10%)

    Order before 4pm tomorrow for delivery by Mon 10 Aug 2026.

    A Hardback by David S. Klimstra, Ralph H. Hruban, Carlie S. Sigel

      Trusted by thousands of customers. See 2,385+ Customer Reviews

      View other formats and editions of Tumors of the Pancreas by David S. Klimstra

      Publisher: American Registry of Pathology
      Publication Date: Publication Date: 30/04/2023
      ISBN13: 9781933477275, 978-1933477275
      ISBN10: 193347727X
      Also in:
      Gastroenterology Oncology Pathology

      Description

      Book Synopsis
      Free digital access available with every print purchase. See inside the book for more details.

      While classification of pancreatic neoplasms has not evolved significantly since 2007, data related to the molecular underpinnings that characterize each type of neoplasm have grown exponentially in the past 15 years. The current multimodal study of pancreatic neoplasms has allowed a better understanding of tumor biology, more closely linking the mor¬phologic findings with clinical outcomes and targeted treatment. The prognosis of conventional pancreatic ductal adenocarcinoma remains very poor, but some promise is on the horizon based on novel treatment approaches and the increase in earlier diagnosis. Furthermore, intensive study of other pancreatic neoplasms has led to a clearer recognition that each type has distinctive biology and behavior that is often not so highly aggressive. This sense of optimism may help drive a resurgence of interest in pancreatic pathology.

      Recently viewed products

      © 2026 Book Curl

        • American Express
        • Apple Pay
        • Diners Club
        • Discover
        • Google Pay
        • Maestro
        • Mastercard
        • PayPal
        • Shop Pay
        • Union Pay
        • Visa

        Login

        Forgot your password?

        Don't have an account yet?
        Create account